The N-methyl-D-aspartate receptor and schizophrenia.
Strous
R D
RD
Department of Psychiatry, Albert Einstein College of Medicine/Bronx Psychiatric Center, New York, USA.
Javitt
D C
DC
D001921:Brain / Q000378:metabolism; D004298:Dopamine / Q000502:physiology; D018691:Excitatory Amino Acid Antagonists / Q000009:adverse effects; D006801:Humans; D007649:Ketamine / Q000009:adverse effects; D008959:Models, Neurological; D010622:Phencyclidine / Q000009:adverse effects; D017448:Receptors, Dopamine D2 / Q000187:drug effects; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects / Q000502:physiology*; D012559:Schizophrenia / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism*
D018691:Excitatory Amino Acid Antagonists; D017448:Receptors, Dopamine D2; D016194:Receptors, N-Methyl-D-Aspartate; D007649:Ketamine; D010622:Phencyclidine; D004298:Dopamine